What does it take to turn breakthrough biology into successful in vivo therapies? As innovations in synthetic biology, RNA editing, and gene therapy continue to accelerate, vector design and manufacturing remain the critical link between scientific discovery and patient impact. Join Chief Editor Erin Harris for a special Cell & Gene Live discussion with Robert...
Rising regulatory expectations and increased scrutiny around particulate contamination are reshaping how risk is managed in bioprocessing. Particulate issues are often identified late in the process, leading to operational disruption, rework, and increased validation burden. This webinar explores how organizations can shift from reactive responses to proactive containment strategies. Using aggregated industry insights and representative...
The discussion will examine key manufacturing challenges and highlight where consumables add value, where they introduce unnecessary complexity, and how early upstream and downstream decisions impact long-term cost, scalability, and risk. Attendees will leave with key points to consider on how to approach consumables as a strategic part of manufacturing, rather than a line-item cost.
Residual host cell DNA (residual DNA) is a critical quality attribute across biologics, vaccines and advanced therapy modalities, requiring sensitive and reproducible quantification to support process development, in-process control and lot release. However, traditional workflows can introduce variability and delay release timelines due to reliance on standard curves, multiple manual steps and method complexity. In...
Discover how innovative media design strategies can help overcome productivity limitations in bioprocessing and drive higher titers without sacrificing product quality. In this webinar, experts will share a data-driven, bottom-up approach to media development using Design of Experiments (DOE) to identify the nutrients that have the greatest impact on cell culture performance. Learn how optimized...
Once a fringe idea in chemical biology, targeted protein degradation (TPD) has become one of the most watched strategies in drug discovery. TPD has created new therapeutic opportunities for previously undruggable protein targets. Leading experts will discuss the design, challenges, and clinical promise of PROTACs in overcoming limitations of traditional small molecules. Ever wonder: How...
In this webinar, Revvity Signals will explore how Signals Clinical applies governed, fit-for-purpose AI within clinical data review workflows. The discussion will focus on practical ways to accelerate review while keeping clinical experts in control.
False rejects are more than a nuisance—they create unnecessary waste, disrupt production efficiency, and erode confidence in inspection systems. In this webinar, we will explore the top 10 causes of false rejects across system setup, environmental conditions, and product and operational variability. We will also demonstrate why false rejects are not inevitable, but instead indicators...
Bioprocess Online's Bio-Expo Live is back with its series of live virtual events designed to empower biopharma professionals. Through these sessions, attendees will have the chance to explore the newest equipment and solutions offered by our presenters, aimed at addressing the current challenges within the drug development process. This interactive online platform ensures convenience and...
Join this webinar to learn how leading cell therapy developers are tackling one of the field’s biggest challenges: scaling non-viral gene-edited cell therapies from research to manufacturing. Through real-world data in T, NK, and CD34+ cells, experts will demonstrate how electroporation can enable efficient CRISPR knock-out, knock-in, and transposon-based editing while preserving critical cell quality...
